Results 71 to 80 of about 225,982 (305)
ROLE OF THE ANTIPLATELET DRUGS IN TREATMENT OF STABLE ANGINA: COMMON SENSE AND NON-RESOLVED ISSUES
Stable angina pectoris is the most prevalent type of ischemic heart disease. In its treatment, the main role play drugs that block adhesion and aggreagation of platelets — antiaggregants.
V. V. Yakusevich +2 more
doaj +1 more source
ABSTRACT Background Cangrelor reduces thrombotic events in patients undergoing percutaneous coronary intervention (PCI), with the advantage of rapid onset and offset. However, premature discontinuation may increase the risk of acute thrombosis for patients undergoing complex/high‐risk PCI (CHIP).
Siyu Ma +8 more
wiley +1 more source
Coronary physiology is widely used to assess epicardial coronary lesions in patients with stable angina. Based on the available evidence, physiology plays a crucial role in diagnosing and treating patients.
Valentin Chioncel +1 more
doaj +1 more source
Modern strategy, management and outcomes for stable ischemic heart disease patients
The analysis provided, of modern tactics for stable ischemic heart disease patients that makes it possible for practitioners to estimate adequately risk and benefits of diagnostic studies, to select medical or surgical treatment method and to assess ...
V. P. Lupanov
doaj +1 more source
Long‐Term Outcomes After Coronary Absorb BVS Implantation Guided by Intravascular Imaging
ABSTRACT Background Coronary artery implantation of the absorb bioresorbable vascular scaffold (BVS) without intravascular imaging (IVI) guidance resulted in greater adverse events compared with metallic drug‐eluting stents during 3‐year follow‐up. Aims We assessed the 10‐year outcomes of BVS implanted with routine use of IVI guidance.
Costantino R. Costantini +8 more
wiley +1 more source
Drugs for hypertension, angina and heart failure [PDF]
12.1 Drugs for hypertension\ud 12.1.1 Epidemiology and pathophysiology\ud 12.1.2 Diuretics for hypertension\ud 12.2.3 Vasodilators for hypertension\ud 12.4.4 β-Adrenoceptor blockers for hypertension\ud 12.2.
Doggrell, Sheila
core
ABSTRACT Background Real‐world data after percutaneous coronary intervention (PCI) using drug‐coated balloons (DCBs) in acute coronary syndrome (ACS) are limited. Aims We compared 1‐year clinical outcomes after PCI with paclitaxel DCBs between the ACS and non‐ACS patients.
Takashi Muramatsu +18 more
wiley +1 more source
The study aim was to assess the importance of adequate administration of medications with negative chronotropic effect in the improvement of clinical course and prognosis among patients with coronary heart disease (CHD) and heart failure. The possibility
M. G. Glezer +2 more
doaj +1 more source
The Triple Wire Dual Angioseal Technique for Large Bore Femoral Access Closure
ABSTRACT There is a growing need for large‐bore femoral access across cardiac interventions. This has led to a need for more widely accessible vascular closure techniques to facilitate reliable vascular closure and wider access to these interventions.
Hilal Khan, Mohaned Egred
wiley +1 more source
The Prevalence and Epidemiological Features of Ischaemic Heart Disease in Sri Lanka
Background: There is limited evidence on the prevalence of ischaemic heart disease (IHD) and its association with risk factors and socioeconomic status (SES) in low- and middle-income countries (LMICs).
Nilmini Wijemunige +3 more
doaj +1 more source

